Brief: India's Caplin Point Laboratories March-Qtr Consol Net Profit Rises
May 28 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* MARCH QUARTER CONSOL NET PROFIT 353.6 MILLION RUPEES
VERSUS
PROFIT 334 MILLION RUPEES YEAR AGO
* MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 1.43 BILLION
RUPEES
VERSUS 1.18 BILLION RUPEES YEAR AGO
* RECOMMENDED FINAL DIVIDEND OF 2 RUPEES PER SHARE
Source text: http://bit.ly/2secgSx
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees